Intention‐to‐Treat Analysis in Randomized Trials: Who Gets Counted?
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
This article discusses the rationale and implications associated with the selection and use of analysis strategies for randomized clinical trials as they relate to protocol deviations. The topics addressed specifically are the conceptual and methodologic approaches and biases of clinical efficacy and effectiveness assessment. Examples are provided that highlight the consequences of different analytic strategies, particularly regarding intention‐to‐treat analysis. Favored by statisticians, intention‐to‐treat analysis seeks to answer the question, “Is it better to adopt a policy of treatment A if possible, with deviations if necessary, or a policy of treatment B if possible, with deviations if necessary?” This is a relevant question, sometimes more relevant than “Is treatment A better than treatment B?” The authors suggest that different analytic strategies may be more or less appropriate depending on the intended audience.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Explanatory and pragmatic attitudes in therapeutical trials
Schwartz, D., & Lellouch, J. (1967) · Journal of Chronic Diseases · doi:10.1016/0021-9681(67)90041-0 · Cited by 1,185
Intention-to-Treat Analysis: Implications for Quantitative and Qualitative Research
NEWELL, D. J. (1992) · International Journal of Epidemiology · doi:10.1093/ije/21.5.837 · Cited by 715
Controversy in Counting and Attributing Events in Clinical Trials
Sackett, D. L., & Gent, M. (1979) · New England Journal of Medicine · doi:10.1056/nejm197912273012602 · Cited by 413
Cited by
A tutorial on sensitivity analyses in clinical trials: the what, why, when and how
Thabane, L., Mbuagbaw, L., Zhang, S., Samaan, Z., Marcucci, M., Ye, C., Thabane, M., Giangregorio, L., Dennis, B., Kosa, D., et al. (2013) · BMC Medical Research Methodology · doi:10.1186/1471-2288-13-92 · Cited by 893
“The potential impact of protocol deviations is the dilution of the treatment effect [26,27].”
BackgroundArmijo-Olivo, S., Warren, S., & Magee, D. (2009) · Physical Therapy Reviews · doi:10.1179/174328809x405928 · Cited by 361
Lamotrigine for Generalized Seizures Associated with the Lennox–Gastaut Syndrome
Motte, J., Trevathan, E., Arvidsson, J. F. V., Barrera, M. N., Mullens, E. L., & Manasco, P. (1997) · New England Journal of Medicine · doi:10.1056/nejm199712183372504 · Cited by 359
Greist, J. H., Marks, I. M., Baer, L., Kobak, K. A., Wenzel, K. W., Hirsch, M. J., Mantle, J. M., & Clary, C. M. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0209 · Cited by 321
Intention-to-treat approach to data from randomized controlled trials: a sensitivity analysis
Wright, C. C., & Sim, J. (2003) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(03)00155-0 · Cited by 171
“Further, there is no universal consensus on adopting ITT as the primary analysis [3,11,30].”
BackgroundInfluential
Metadata
- Authors
- Gibaldi, M., & Sullivan, S.
- Venue
- The Journal of Clinical Pharmacology
- Publisher
- Wiley
- Published
- 1997-08
- Volume
- 37
- Issue
- 8
- Pages
- 667-672
- ISSN
- 0021-9754 (ISSN-L)
- 0091-2700
- 1552-4604
- OpenAlex
- W2007079593
- Cited by
- 28
- References
- 3
- FWCI
- 1.28
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Intention‐to‐Treat Analysis in Randomized Trials: Who Gets Counted? https://app.cochat.ai/papers/10.1002/j.1552-4604.1997.tb04353.x
- The paper
- Gibaldi, M., & Sullivan, S. (1997). Intention‐to‐Treat Analysis in Randomized Trials: Who Gets Counted? The Journal of Clinical Pharmacology. https://doi.org/10.1002/j.1552-4604.1997.tb04353.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.